Natixis’s Hims & Hers Health HIMS Stock Holding History

Natixis’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.62K	Sell	191 -3	-2%	-$81	﹤0.01%	1090
2026 Q1	$4.03K	Buy	+194	New	+$4.58K	﹤0.01%	1041

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Natixis's HIMS Position: Q2 2026 in Review

Natixis reduced its Hims & Hers Health (HIMS) stake by 1.5% in Q2 2026, selling an estimated $81 and leaving 191 shares worth $6.62K. The position accounts for ﹤0.01% of the portfolio, ranked #1090.

Natixis first reported a position in HIMS in Q1 2026 and has held it in 2 quarters since. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

Natixis held 191 shares of Hims & Hers Health worth $6.62K as of Q2 2026.
Natixis sold 3 Hims & Hers Health shares in Q2 2026, an estimated $81.
Hims & Hers Health made up ﹤0.01% of Natixis's portfolio in Q2 2026, its #1090 holding.
Natixis first reported a position in Hims & Hers Health in Q1 2026 and has held it in 2 quarters since.
506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.